New York Assembly Bill A09503

New York 2025-2026 Regular Session

• Introduced: 1/8/26
• Refer: 1/8/26
• Report Pass: 1/20/26
• Refer: 1/20/26
• Report Pass: 1/21/26
• Engrossed: 1/21/26
• Refer: 1/21/26
• Engrossed: 1/28/26
• Enrolled: 2/13/26
• Chaptered: 2/13/26
• Passed: 2/13/26

Caption

Restricts certain substances from being used in menstrual products; relates to the effectiveness of such provisions.

Impact

If enacted, A09503 will significantly alter the landscape of product safety regulations in New York. The bill mandates that menstrual products cannot contain certain restricted substances at any level deemed unsafe. This legislation aligns with broader health initiatives to protect consumers from exposure to harmful chemicals, thereby promoting safer periods for individuals who menstruate. The bill's effective dates suggest a structured timeline for compliance, with the aim to have new standards in place by early 2029.

Summary

Bill A09503 introduces amendments to the general business law, focusing on the restriction of harmful substances in menstrual products sold or distributed in New York. The bill explicitly names substances such as lead, mercury, and various other chemicals deemed unsafe for inclusion in these products. This legislative move aims to enhance consumer safety by ensuring that products are free from toxic materials that could pose health risks to users.

Contention

There may be points of contention regarding the implementation and regulation of these restrictions. Critics could argue about the potential economic implications for manufacturers, who may face increased production costs or challenges adjusting to new regulations. Additionally, the specifics of how the 'restricted substances' will be defined and monitored by health authorities may lead to debates about the adequacy of health standards and consumer protection measures. Balancing public health needs with industry compliance will likely be a central issue during the legislative discussions surrounding this bill.